However, the findings did not evidence an expression pattern in cancer: the overexpression of ATGL was described in high-grade tumors, among which were pancreatic adenocarcinoma [56] and cervical cancer [57], whereas the reduction of ATGL expression was observed in liver and lung cancer [50,58]. This evidence concerns the gene PNPLA2 and cancer.